Literature DB >> 26262596

Facile Construction of Near Infrared Fluorescence Nanoprobe with Amphiphilic Protein-Polymer Bioconjugate for Targeted Cell Imaging.

Zhongyun Liu1,2, Na Chen3, Chunhong Dong1, Wei Li4, Weisheng Guo1, Hanjie Wang1, Sheng Wang1, Jian Tan4, Yu Tu3, Jin Chang1.   

Abstract

A simple, straightforward, and reproducible strategy for the construction of a near-infrared (NIR) fluorescence nanoprobe was developed by coating CuInS2/ZnS quantum dots (CIS/ZnS QDs) with a novel amphiphilic bioconjugate. The amphiphilic bioconjugate with a tailor-designed structure of bovine serum albumin (BSA) as the hydrophilic segment and poly(ε-caprolactone) (PCL) as the hydrophobic part was fabricated by chemical coupling the hydrophobic polymer chain to BSA via the maleimide-sulfhydryl reaction. By incorporating CIS/ZnS QDs into the hydrophobic cores of the self-assembly of BSA-PCL conjugate, the constructed NIR fluorescence nanoprobe exhibited excellent fluorescent properties over a wide pH range (pH 3-10) and a good colloidal stability in PBS buffer (pH = 7.4) with or without 10% fetal bovine serum. The presence of the outer BSA shell effectively reduced the nonspecific cellular binding and imparted high biocompatibility and low-toxicity to the probe. Moreover, the NIR fluorescence nanoprobe could be functionalized by conjugating cyclic Arg-Gly-Asp (cRGD) peptide, and the decorated nanoprobe was shown to be highly selective for targeted integrin αvβ3-overexpressed tumor cell imaging. The feasibility of the constructed NIR fluorescence probe in vivo application was further investigated and the results demonstrated its great potential for in vivo imaging. This developed protocol for phase transfer of the CIS/ZnS QDs was universal and applicable to other nanoparticles stabilized with hydrophobic ligands.

Entities:  

Keywords:  BSA; CuInS2/ZnS quantum dots; fluorescence nanoprobe; protein-polymer conjugate; self-assembly

Mesh:

Substances:

Year:  2015        PMID: 26262596     DOI: 10.1021/acsami.5b05406

Source DB:  PubMed          Journal:  ACS Appl Mater Interfaces        ISSN: 1944-8244            Impact factor:   9.229


  4 in total

Review 1.  Potential applications and human biosafety of nanomaterials used in nanomedicine.

Authors:  Hong Su; Yafei Wang; Yuanliang Gu; Linda Bowman; Jinshun Zhao; Min Ding
Journal:  J Appl Toxicol       Date:  2017-06-06       Impact factor: 3.446

2.  Therapy of cervical cancer using 131I-labeled nanoparticles.

Authors:  Wei Li; Danyang Sun; Ning Li; Yiming Shen; Yiming Hu; Jian Tan
Journal:  J Int Med Res       Date:  2018-04-16       Impact factor: 1.671

3.  Insight into the preformed albumin corona on in vitro and in vivo performances of albumin-selective nanoparticles.

Authors:  Zhenbao Li; Dan Li; Wenjuan Zhang; Peng Zhang; Qiming Kan; Jin Sun
Journal:  Asian J Pharm Sci       Date:  2018-08-09       Impact factor: 6.598

Review 4.  Strategies for Preparing Albumin-based Nanoparticles for Multifunctional Bioimaging and Drug Delivery.

Authors:  Fei-Fei An; Xiao-Hong Zhang
Journal:  Theranostics       Date:  2017-08-23       Impact factor: 11.556

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.